60 day FRN

jspears on DSK121TN23PROD with NOTICES1

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
National Center for Emerging and
Zoonotic Infectious Diseases, CDC, 1600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329–4027,
Telephone: (404) 718–8039; Email:
[email protected].

Prevention and the Agency for Toxic
Substances and Disease Registry.

SUPPLEMENTARY INFORMATION:

[FR Doc. 2022–03038 Filed 2–11–22; 8:45 am]

Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; the Isolation Precautions
Guideline Workgroup; and the Neonatal
Intensive Care Unit Workgroup. Agenda
items are subject to change as priorities
dictate.
Procedures for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Procedures for Written Comment: The
public may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is March 18, 2022. All
requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and

BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0728; Docket No. CDC–2022–
0020]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Notifiable Diseases
Surveillance System (NNDSS). The
purpose of this data collection is to
provide the official source of statistics
in the United States for nationally
notifiable conditions.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0020 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
SUMMARY:

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

8257

proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Notifiable Diseases
Surveillance System (NNDSS) (OMB
Control No. 0920–0728, Exp. 3/31/
2024)—Revision—Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The National

E:\FR\FM\14FEN1.SGM

14FEN1

8258

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices

Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels
because of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Each year, the Council of State
and Territorial Epidemiologists (CSTE),
supported by CDC, determines which
reportable conditions should be
designated nationally notifiable or
under standardized surveillance.
CDC requests a three-year approval for
a Revision for the NNDSS (OMB Control
No. 0920–0728, Expiration Date 03/31/
2024).
This Revision includes requests for
approval to: (1) Receive case notification
data for Alpha-gal syndrome (AGS), a
new condition under standardized
surveillance (CSS); (2) receive Sexual
Orientation and Gender Identity (SOGI)
and Birth Sex data elements (with
United States Core Data for
Interoperability (USCDI) value sets) for
sexually transmitted diseases (STD) and
Hepatitis; (3) receive an extension of
three years to continue to receive the
current SOGI data elements for STD;
and (4) receive new disease-specific
data elements for Hepatitis and AGS.
The NNDSS currently facilitates the
submission and aggregation of case
notification data voluntarily submitted
to CDC from 60 jurisdictions: Public
health departments in every U.S. state,
New York City, Washington DC, five

Recommended Security Controls for
Federal Information Systems and
Organizations. Weekly tables of
nationally notifiable diseases are
available through CDC WONDER and
data.cdc.gov. Annual summaries of
finalized nationally notifiable disease
data are published on CDC WONDER
and data.cdc.gov and disease-specific
data are published by individual CDC
programs.
The burden estimates include the
number of hours that the public health
department uses to process and send
case notification data from their
jurisdiction to CDC. Specifically, the
burden estimates include separate
burden hours incurred for automated
and non-automated transmissions,
separate weekly burden hours incurred
for modernizing surveillance systems as
part of NNDSS Modernization Initiative
(NMI) implementation, separate burden
hours incurred for annual data
reconciliation and submission, and
separate one-time burden hours
incurred for the addition of new
diseases and data elements. The burden
estimates for the one-time burden for
reporting jurisdictions are for the
addition of case notification data for
Alpha-gal syndrome (AGS), a new
condition under standardized
surveillance (CSS); Sexual Orientation
and Gender Identity (SOGI) and Birth
Sex data elements for sexually
transmitted diseases (STD) and
Hepatitis; and new disease-specific data
elements for Hepatitis and AGS. The
estimated annual burden for the 257
respondents is 18,294 hours, which has
decreased from the previously-approved
18,954 hours in the last Revision.

U.S. territories (American Samoa, the
Commonwealth of Northern Mariana
Islands, Guam, Puerto Rico, and the U.S.
Virgin Islands), and three freely
associated states (Federated States of
Micronesia, the Republic of the
Marshall Islands, and the Republic of
Palau). This information is shared
across jurisdictional boundaries and
both surveillance and prevention and
control activities are coordinated at
regional and national levels.
Approximately 90% of case
notifications are encrypted and
submitted to NNDSS electronically from
already existing databases by automated
electronic messages. When automated
transmission is not possible, case
notifications are faxed, emailed,
uploaded to a secure network or entered
into a secure website. All case
notifications that are faxed or emailed
are done so in the form of an aggregate
weekly or annual report, not individual
cases. These different mechanisms used
to send case notifications to CDC vary
by the jurisdiction and the disease or
condition. Jurisdictions remove most
personally identifiable information (PII)
before data are submitted to CDC, but
some data elements (e.g., date of birth,
date of diagnosis, county of residence)
could potentially be combined with
other information to identify
individuals. Private information is not
disclosed unless otherwise compelled
by law. All data are treated in a secure
manner consistent with the technical,
administrative, and operational controls
required by the Federal Information
Security Management Act of 2002
(FISMA) and the 2010 National Institute
of Standards and Technology (NIST)

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent

States
States
States
States
States

................................................
................................................
................................................
................................................
................................................

jspears on DSK121TN23PROD with NOTICES1

Territories
Territories
Territories
Territories
Territories
Freely
Freely
Freely
Freely

..........................................
..........................................
..........................................
..........................................
..........................................

Associated
Associated
Associated
Associated

States
States
States
States

..................
..................
..................
..................

Cities .................................................
Cities .................................................
Cities .................................................

VerDate Sep<11>2014

17:54 Feb 11, 2022

Weekly (Automated) .........................
Weekly (Non-automated) .................
Weekly (NMI Implementation) ..........
Annual ..............................................
One-time Addition of Diseases and
Data Elements.
Weekly (Automated) .........................
Weekly, Quarterly (Non-automated)
Weekly (NMI Implementation) ..........
Annual ..............................................
One-time Addition of Diseases and
Data Elements.
Weekly (Automated) .........................
Weekly, Quarterly (Non-automated)
Annual ..............................................
One-time Addition of Diseases and
Data Elements.
Weekly (Automated) .........................
Weekly (Non-automated) .................
Weekly (NMI Implementation) ..........

Jkt 256001

PO 00000

Frm 00032

Number of
responses per
respondent

Number of
respondents

Form name

Fmt 4703

Sfmt 4703

Average
burden per
response
(in hours)

Total burden
(in hours)

50
10
50
50
50

52
52
52
1
1

20/60
2
4
75
1

867
1,040
10,400
3,750
50

5
5
5
5
5

52
56
52
1
1

20/60
20/60
4
5
1

87
93
1,040
25
5

3
3
3
3

52
56
1
1

20/60
20/60
5
1

52
56
15
3

2
2
2

52
52
52

20/60
2
4

35
208
416

E:\FR\FM\14FEN1.SGM

14FEN1

8259

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Cities .................................................
Cities .................................................

Annual ..............................................
One-time Addition of Diseases and
Data Elements.

2
2

1
1

75
1

150
2

Total ...........................................

...........................................................

........................

........................

........................

18,294

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03078 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–2022–1050; Docket No. CDC–2022–
0025]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC/ATSDR Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery.
The information collection activities
provide a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the federal
government’s commitment to improving
service delivery.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0025 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
SUMMARY:

jspears on DSK121TN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondent

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CDC/ATSDR Generic Clearance for
the Collection of Qualitative Feedback
on Agency Service Delivery (OMB
Control No. 0920–1050, Exp. 5/31/
2022)—Extension—Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The information collection activities
associated with this Generic clearance
provide a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the federal
government’s commitment to improving
service delivery. By qualitative
feedback, information will be collected
that provides useful insights on
perceptions and opinions, but are not
statistical surveys that yield quantitative
results that can be generalized to the
population of study.
Feedback from respondents will
provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between
CDC and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
The solicitation of feedback will target
areas such as: Timeliness,

E:\FR\FM\14FEN1.SGM

14FEN1